Dr. Isaac Teitelbaum, MD

Dr. Teitelbaum practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Teitelbaum's NPI, 1235229139, was assigned on October 13, 2006. Dr. Teitelbaum graduated from State University of New York Downstate Medical Center in 1979. Dr. Teitelbaum holds Colorado license 23356.

Dr. Teitelbaum's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Teitelbaum's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Teitelbaum is also affiliated with UCHealth Highlands Ranch Hospital. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Teitelbaum to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Teitelbaum practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Teitelbaum's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Teitelbaum is licensed in Colorado.

CMS data shows 488 Medicare services from Dr. Teitelbaum across 6 procedure codes in 2024, for 172 Medicare patients. Medicare paid $69,253 for them.

CMS counts 172 Medicare patients who saw Dr. Teitelbaum in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 5.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Teitelbaum's median patient age at 66, with 47% women.

In 2024, Dr. Teitelbaum wrote 387 Medicare Part D claims for 44 patients. 92% of them were for generic drugs. CMS names the drug for 218 of them, across 11 drugs with 11 or more claims each, at $13,951 in total drug cost. In 2023, CMS named 104 claims across 5 drugs.

Dr. Teitelbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Teitelbaum as offering telehealth.

Dmand AI links 53 papers to Dr. Teitelbaum, published from 2011 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Peritoneal Dialysis, Kidney Failure, Chronic and Peritonitis. Dr. Teitelbaum has published most often in Perit Dial Int. Dr. Teitelbaum's most frequent co-authors are John Mark Burkart, MD, Jenny I. Shen, MD and Fredric O. Finkelstein, MD.

CMS Open Payments shows 39 general payments to Dr. Teitelbaum from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. AstraZeneca Pharmaceuticals LP paid the most, $6,510.

Dr. Teitelbaum graduated from State University of New York Downstate Medical Center in 1979.